Virtual Medicinal Product (VMP) - Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free

Navigation

Name Details

Name Start Date End Date
Name Current Name Buprenorphine 8mg / Naloxone 2mg sublingual tablets sugar free Start Date 08-01-2007 End Date
Abbreviated Name Abbreviated Name Buprenorphine 8mg / Naloxone 2mg sublingual tab sugar free Start Date 01-05-2009
Previous Abbreviated Name Buprenorphine 8mg / Naloxone 2mg sublingual tablets SF Previous Start Date 08-01-2007 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 3 (CD No Register)
Route
Sublingual
Form
Sublingual tablet
Ontology Form/Route
tabletsublingual.oromucosal
Free From
Sugar-free
Name Basis
Other

Codes

ATC Code
N07BC51
BNF Start Date End Date
Current BNF 04100300 Start Date 04-04-2022 End Date
Previous BNF 04100300 Start Date 05-04-2011 End Date 03-04-2022
Previous BNF 04100000 Start Date 11-04-2007 End Date 04-04-2011
SNOMED Codes
Code Start Date End Date
11055911000001101 08-01-2007

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Buprenorphine hydrochloride Based on Base Substance Buprenorphine 8 mg
Naloxone hydrochloride dihydrate Based on Base Substance Naloxone 2 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet 7619 Part VIIIA Category C